Three Months Ended March 31, | ||||
(in millions, except per share data) | 2021 | 2020 | ||
Net sales | $ | 3,819 | $ | 3,511 |
Cost of sales | 3,521 | 3,274 | ||
Gross profit | 298 | 237 | ||
Selling, general and administrative expenses | 148 | 127 | ||
Restructuring and impairment costs | 5 | 52 | ||
Equity income (loss) | 85 | 8 | ||
Earnings (loss) before interest and income taxes | 230 | 66 | ||
Net financing charges | 110 | 50 | ||
Other pension expense (income) | (2) | (2) | ||
Income (loss) before income taxes | 122 | 18 | ||
Income tax provision (benefit) | 28 | 16 | ||
Net income (loss) | 94 | 2 | ||
Income attributable to noncontrolling interests | 25 | 21 | ||
Net income (loss) attributable to Adient | $ | 69 | $ | (19) |
Diluted earnings (loss) per share | $ | 0.72 | $ | (0.20) |
Shares outstanding at period end | 94.2 | 93.9 | ||
Diluted weighted average shares | 96.0 | 93.8 |
March 31, | September 30, | |||
(in millions) | 2021 | 2020 | ||
Assets | ||||
Cash and cash equivalents | $ | 984 | $ | 1,692 |
Accounts receivable - net
| 1,757 | 1,641 | ||
Inventories | 756 | 685 | ||
Assets held for sale | 56 | 43 | ||
Other current assets | 537 | 421 | ||
Current assets | 4,090 | 4,482 | ||
Property, plant and equipment - net | 1,551 | 1,581 | ||
Goodwill | 2,059 | 2,057 | ||
Other intangible assets - net | 432 | 443 | ||
Investments in partially-owned affiliates | 848 | 707 | ||
Assets held for sale | 26 | 27 | ||
Other noncurrent assets | 969 | 964 | ||
Total assets | $ | 9,975 | $ | 10,261 |
Liabilities and Shareholders' Equity | ||||
Short-term debt | $ | 22 | $ | 210 |
Accounts payable and accrued expenses | 2,754 | 2,553 | ||
Liabilities held for sale | 60 | 46 | ||
Other current liabilities | 825 | 1,010 | ||
Current liabilities | 3,661 | 3,819 | ||
Long-term debt | 3,646 | 4,097 | ||
Other noncurrent liabilities | 782 | 767 | ||
Redeemable noncontrolling interests | 44 | 43 | ||
Shareholders' equity attributable to Adient | 1,489 | 1,213 | ||
Noncontrolling interests | 353 | 322 | ||
Total liabilities and shareholders' equity | $ | 9,975 | $ | 10,261 |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Operating Activities | ||||
Net income (loss) attributable to Adient | $ | 69 | $ | (19) |
Income attributable to noncontrolling interests | 25 | 21 | ||
Net income (loss) | 94 | 2 | ||
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | ||||
Depreciation | 69 | 72 | ||
Amortization of intangibles | 9 | 10 | ||
Pension and postretirement contributions, net | (3) | (14) | ||
Equity in earnings of partially-owned affiliates, net of dividends received | (43) | (1) | ||
Gain on sale of a nonconsolidated partially-owned affiliate | (33) | - | ||
Premium and transaction costs paid on repurchase of debt | 46 | - | ||
Deferred income taxes | (1) | 10 | ||
Non-cash restructuring and impairment charges | 4 | - | ||
Equity-based compensation | 13 | (3) | ||
Other | 9 | 2 | ||
Changes in assets and liabilities: | ||||
Receivables | (366) | 113 | ||
Inventories | (65) | (53) | ||
Other assets | (7) | 40 | ||
Restructuring reserves | (42) | (15) | ||
Accounts payable and accrued liabilities | 219 | (199) | ||
Accrued income taxes | 6 | (20) | ||
Cash provided (used) by operating activities | (91) | (56) | ||
Investing Activities | ||||
Capital expenditures | (55) | (94) | ||
Sale of property, plant and equipment | 2 | 4 | ||
Settlement of cross-currency interest rate swap | - | 10 | ||
Receipt of deferred consideration | 19 | - | ||
Cash provided (used) by investing activities | (34) | (80) | ||
Financing Activities | ||||
Increase (decrease) in short-term debt | 3 | 835 | ||
Repayment of long-term debt, including premium paid | (687) | (2) | ||
Debt financing costs | (1) | (1) | ||
Dividends paid to noncontrolling interests | (7) | (5) | ||
Other | (2) | (1) | ||
Cash provided (used) by financing activities | (694) | 826 | ||
Effect of exchange rate changes on cash and cash equivalents | (13) | (15) | ||
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale | (832) | 675 | ||
Less: Change in cash classified within current assets held for sale | (4) | - | ||
Increase (decrease) in cash and cash equivalents | $ | (836) | $ | 675 |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Net Sales | ||||
Americas | $ | 1,644 | $ | 1,641 |
EMEA | 1,636 | 1,488 | ||
Asia | 588 | 444 | ||
Eliminations | (49) | (62) | ||
Total net sales | $ | 3,819 | $ | 3,511 |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Adjusted EBITDA | ||||
Americas | $ | 64 | 106 | |
EMEA | 141 | 62 | ||
Asia | 121 | 63 | ||
Corporate-related costs (1)
| (23) | (20) | ||
Restructuring and impairment costs (2)
| (5) | (52) | ||
Purchase accounting amortization (3)
| (10) | (11) | ||
Restructuring related charges (4)
| (2) | (7) | ||
Gain on sale of interest in a nonconsolidated partially owned affiliate | 33 | - | ||
Stock based compensation | (13) | 3 | ||
Depreciation | (69) | (72) | ||
Other items (5)
| (7) | (6) | ||
Earnings (loss) before interest and income taxes | 230 | 66 | ||
Net financing charges | (110) | (50) | ||
Other pension income (expense) | 2 | 2 | ||
Income (loss) before income taxes | $ | 122 | $ | 18 |
Three Months Ended March 31, | ||||
(in millions, except per share data) | 2021 | 2020 | ||
Income available to shareholders | ||||
Net income (loss) attributable to Adient | $ | 69 | $ | (19) |
Weighted average shares outstanding | ||||
Basic weighted average shares outstanding | 94.2 | 93.8 | ||
Effect of dilutive securities: | ||||
Stock options, unvested restricted stock and unvested performance share awards | 1.8 | - | ||
Diluted weighted average shares outstanding | 96.0 | 93.8 |
• | Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. |
• | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. |
• | Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, expenses associated with becoming an independent company, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. |
• | Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. |
• | Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares. |
• | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income. |
• | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. |
• | Free cash flow is defined as cash provided by operating activities less capital expenditures. |
• | Net debt is calculated as gross debt (short-term and long-term) less cash and cash equivalents. |
Three Months Ended March 31, | ||||||||||||
2021 | 2020 | |||||||||||
(in millions, except per share data) | GAAP Results | Adj. | Adjusted Results | GAAP Results | Adj. | Adjusted Results | ||||||
Net sales | $ | 3,819 | $ | - | $ | 3,819 | $ | 3,511 | $ | - | $ | 3,511 |
Cost of sales (6)
| 3,521 | (1) | 3,520 | 3,274 | (3) | 3,271 | ||||||
Gross profit | 298 | 1 | 299 | 237 | 3 | 240 | ||||||
Selling, general and administrative expenses (7)
| 148 | (17) | 131 | 127 | (19) | 108 | ||||||
Restructuring and impairment costs (2)
| 5 | (5) | - | 52 | (52) | - | ||||||
Equity income (loss) (8)
| 85 | (32) | 53 | 8 | 2 | 10 | ||||||
Earnings (loss) before interest and income taxes (EBIT) | 230 | (9) | 221 | 66 | 76 | 142 | ||||||
Memo accounts: | ||||||||||||
Depreciation | 69 | 72 | ||||||||||
Equity based compensation | 13 | (3) | ||||||||||
Adjusted EBITDA | $ | 303 | $ | 211 | ||||||||
Net financing charges (9)
| 110 | (50) | 60 | 50 | - | 50 | ||||||
Other pension expense (income) | (2) | - | (2) | (2) | - | (2) | ||||||
Income (loss) before income taxes | 122 | 41 | 163 | 18 | 76 | 94 | ||||||
Income tax provision (benefit) (10)
| 28 | (2) | 26 | 16 | (3) | 13 | ||||||
Net income (loss) attributable to Adient | 69 | 41 | 110 | (19) | 77 | 58 | ||||||
Diluted earnings (loss) per share | 0.72 | 0.43 | 1.15 | (0.20) | 0.82 | 0.62 | ||||||
Diluted weighted average shares | 96.0 | - | 96.0 | 93.8 | 0.4 | 94.2 |
Three months ended March 31, 2021 | ||||||||||
Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||
Net sales | $ | 1,644 | $ | 1,636 | $ | 588 | $ | (49) | $ | 3,819 |
Adjusted EBITDA | $ | 64 | $ | 141 | $ | 121 | $ | (23) | $ | 303 |
Adjusted EBITDA margin | 3.9 | % | 8.6 | % | 20.6 | % | N/A | 7.9 | % | |
Three months ended March 31, 2020 | ||||||||||
Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||
Net sales | $ | 1,641 | $ | 1,488 | $ | 444 | $ | (62) | $ | 3,511 |
Adjusted EBITDA | $ | 106 | $ | 62 | $ | 63 | $ | (20) | $ | 211 |
Adjusted EBITDA margin | 6.5 | % | 4.2 | % | 14.2 | % | N/A | 6.0 | % |
Three Months Ended March 31, | ||||||||||
2021 | 2020 | |||||||||
(in millions, except effective tax rate) | Income (loss) before income taxes | Tax impact | Effective tax rate | Income (loss) before income taxes | Tax impact | Effective tax rate | ||||
As reported | $ | 122 | $ | 28 | 23.0% | $ | 18 | $ | 16 | 88.9% |
Adjustments | 41 | (2) | (4.9)% | 76 | (3) | (3.9)% | ||||
As adjusted | $ | 163 | $ | 26 | 16.0% | $ | 94 | $ | 13 | 13.8% |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Net income (loss) attributable to Adient | $ | 69 | $ | (19) |
Restructuring and impairment costs
| 5 | 52 | ||
Purchase accounting amortization
| 10 | 11 | ||
Restructuring related charges
| 2 | 7 | ||
Gain on sale of interest in a nonconsolidated partially owned affiliate | (33) | - | ||
Write off of deferred financing charges upon repurchase of debt | 10 | - | ||
Interest accretion on deferred consideration | (5) | - | ||
Premium paid on repurchase of debt | 45 | - | ||
Other items (5)
| 7 | 6 | ||
Impact of adjustments on noncontrolling interests (11)
| (2) | (2) | ||
Tax impact of above adjustments and other tax items (10)
| 2 | 3 | ||
Adjusted net income attributable to Adient | $ | 110 | $ | 58 |
Three Months Ended March 31, | ||||
2021 | 2020 | |||
Diluted earnings (loss) per share as reported | $ | 0.72 | $ | (0.20) |
Restructuring and impairment costs | 0.05 | 0.55 | ||
Purchase accounting amortization | 0.10 | 0.12 | ||
Restructuring related charges | 0.02 | 0.08 | ||
Gain on sale of interest in a nonconsolidated partially owned affiliate | (0.33) | - | ||
Write off of deferred financing charges upon repurchase of debt | 0.10 | - | ||
Interest accretion on deferred consideration | (0.05) | - | ||
Premium paid on repurchase of debt | 0.47 | - | ||
Other items (5)
| 0.07 | 0.06 | ||
Impact of adjustments on noncontrolling interests (11)
| (0.02) | (0.02) | ||
Tax impact of above adjustments and other tax items (10)
| 0.02 | 0.03 | ||
Adjusted net income attributable to Adient | $ | 1.15 | $ | 0.62 |
March 31, | September 30, | |||
(in millions) | 2021 | 2020 | ||
Cash and cash equivalents | $ | 984 | $ | 1,692 |
Total short-term and long-term debt | 3,668 | 4,307 | ||
Net debt | $ | 2,684 | $ | 2,615 |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Cash provided by operating activities | $ | (91) | $ | (56) |
Capital expenditures | (55) | $ | (94) | |
Free cash flow | $ | (146) | $ | (150) |
FY21 | FY20 | |||||||
(in millions) | Q2 | YTD | Q2 | YTD | ||||
Adjusted EBITDA | $ | 303 | $ | 681 | $ | 211 | $ | 508 |
(+/-) Net equity in earnings | (45) | (138) | (3) | (110) | ||||
(-) Restructuring (cash) | (45) | (100) | (20) | (40) | ||||
(+/-) Net customer tooling | 8 | - | (8) | (2) | ||||
(+/-) Trade working capital (Net AR/AP + Inventory) | (153) | 97 | (103) | 99 | ||||
(+/-) Accrued compensation | 27 | 8 | (23) | (84) | ||||
(-) Interest paid | (70) | (136) | (56) | (105) | ||||
(+/-) Tax refund/taxes paid | (20) | (32) | (26) | (55) | ||||
(+/-) Non-income related taxes (VAT) | (11) | (78) | 1 | - | ||||
(+/-) Commercial settlements | (70) | (79) | (21) | (2) | ||||
(+/-) Other | (15) | (83) | (8) | (26) | ||||
Operating cash flow | (91) | 140 | (56) | 183 | ||||
Capital expenditures | (55) | (126) | (94) | (185) | ||||
Free cash flow | $ | (146) | $ | 14 | $ | (150) | $ | (2) |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Restructuring charges | $ | (3) | $ | (52) |
Held for sale asset adjustments | (2) | - | ||
$ | (5) | $ | (52) |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Transaction costs | $ | (7) | $ | (6) |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Restructuring related charges | $ | (1) | $ | (3) |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Purchase accounting amortization | $ | (9) | $ | (10) |
Transaction costs | (7) | (6) | ||
Restructuring related charges | (1) | (3) | ||
$ | (17) | $ | (19) |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Gain on sale of interest in a nonconsolidated partially owned affiliate | $ | (33) | $ | - |
Restructuring related charges | - | 1 | ||
Purchase accounting amortization | 1 | 1 | ||
$ | (32) | $ | 2 |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Premium paid on repurchase of debt | $ | (45) | $ | - |
Write off of deferred financing charges upon repurchase of debt | (10) | - | ||
Interest accretion on deferred consideration | 5 | - | ||
$ | (50) | $ | - |
Three Months Ended March 31, | ||||
(in millions) | 2021 | 2020 | ||
Benefits associated with restructuring and impairment charges | $ | (1) | $ | - |
Gain on sale of interest in a nonconsolidated partially owned affiliate | 5 | - | ||
Tax rate change | - | (1) | ||
Other reconciling items | (2) | 4 | ||
$ | 2 | $ | 3 |
Attachments
- Original document
- Permalink
Disclaimer
Adient plc published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2021 20:15:59 UTC.